K A Strydom1,2, L Chen3, M M Kock1,2, A C Stoltz1, G Peirano4,5, D B Nobrega6, M Lowe1,2, M M Ehlers1,2, N M Mbelle1,2, B N Kreiswirth3, J D D Pitout1,4,5. 1. University of Pretoria, Pretoria, Gauteng, South Africa. 2. National Health Laboratory Service, Pretoria, Gauteng, South Africa. 3. Hackensack Meridian Health, Nutley, NJ, USA. 4. Alberta Public Laboratories, Calgary, Alberta, Canada. 5. Cummings School of Medicine, Calgary, Alberta, Canada. 6. Faculty of Veterinary Medicine, Calgary, Alberta, Canada and University of Calgary Calgary, Alberta, Canada.
Abstract
INTRODUCTION: Klebsiella pneumoniae with OXA-48-like enzymes were introduced into Tshwane Tertiary Hospital (TTH) (Pretoria, South Africa) during September 2015, causing nosocomial outbreaks. METHODS: PCR methodologies and WGS were used to characterize K. pneumoniae with carbapenemases (n = 124) from TTH (July 2015-December 2016). RESULTS: PCR was used to track K. pneumoniae ST307 with OXA-181 among 60% of carbapenemase-positive isolates in different wards/units over time and showed the transmission of IncX3 plasmids to other K. pneumoniae clones. WGS identified different ST307 clades: 307_OXA181 (consisting of two lineages, A and B) with OXA-181 on IncX3 plasmids (named p72_X3_OXA181) and clade 307_VIM with VIM-1 on IncFII plasmids. Clade 307_OXA181 lineage B was responsible for the rapid increase and transmission of OXA-181 K. pneumoniae in various wards/units throughout TTH, while the numbers of clade 307_OXA181 lineage A and clade 307_VIM remained low. Separate outbreaks were due to K. pneumoniae ST17 and ST29 with p72_X3_OXA181 plasmids. CONCLUSIONS: The high-risk clone K. pneumoniae ST307 with OXA-181 rapidly spread to different wards/units despite infection and prevention measures. ST307 clades and lineages seemingly acted differently in outbreak situations. This study also highlighted the threat of promiscuous plasmids such as p72_X3_OXA181.
INTRODUCTION:Klebsiella pneumoniae with OXA-48-like enzymes were introduced into Tshwane Tertiary Hospital (TTH) (Pretoria, South Africa) during September 2015, causing nosocomial outbreaks. METHODS: PCR methodologies and WGS were used to characterize K. pneumoniae with carbapenemases (n = 124) from TTH (July 2015-December 2016). RESULTS: PCR was used to track K. pneumoniae ST307 with OXA-181 among 60% of carbapenemase-positive isolates in different wards/units over time and showed the transmission of IncX3 plasmids to other K. pneumoniae clones. WGS identified different ST307 clades: 307_OXA181 (consisting of two lineages, A and B) with OXA-181 on IncX3 plasmids (named p72_X3_OXA181) and clade 307_VIM with VIM-1 on IncFII plasmids. Clade 307_OXA181 lineage B was responsible for the rapid increase and transmission of OXA-181 K. pneumoniae in various wards/units throughout TTH, while the numbers of clade 307_OXA181 lineage A and clade 307_VIM remained low. Separate outbreaks were due to K. pneumoniae ST17 and ST29 with p72_X3_OXA181 plasmids. CONCLUSIONS: The high-risk clone K. pneumoniae ST307 with OXA-181 rapidly spread to different wards/units despite infection and prevention measures. ST307 clades and lineages seemingly acted differently in outbreak situations. This study also highlighted the threat of promiscuous plasmids such as p72_X3_OXA181.
Authors: Maria A Jure; Marta E Castillo; Humberto E Musa; Carolina G López; Mariel A Cáceres; Silvana D Mochi; Aurore A Bousquet; Nathalie A Genel; Guillaume A Arlet; Dominique C Decré Journal: J Glob Antimicrob Resist Date: 2019-03-22 Impact factor: 4.035
Authors: Michelle Lowe; Marleen M Kock; Jennifer Coetzee; Ebrahim Hoosien; Gisele Peirano; Kathy-Ann Strydom; Marthie M Ehlers; Nontombi M Mbelle; Elena Shashkina; David B Haslam; Puneet Dhawan; Robert J Donnelly; Liang Chen; Barry N Kreiswirth; Johann D D Pitout Journal: Emerg Infect Dis Date: 2019-04 Impact factor: 6.883
Authors: Marta Aires-de-Sousa; José Manuel Ortiz de la Rosa; Maria Luísa Gonçalves; Ana Luísa Pereira; Patrice Nordmann; Laurent Poirel Journal: Emerg Infect Dis Date: 2019-09 Impact factor: 6.883
Authors: Sara E Boyd; Alison Holmes; Richard Peck; David M Livermore; William Hope Journal: Antimicrob Agents Chemother Date: 2022-07-20 Impact factor: 5.938
Authors: William C Shropshire; An Q Dinh; Michelle Earley; Lauren Komarow; Diana Panesso; Kirsten Rydell; Sara I Gómez-Villegas; Hongyu Miao; Carol Hill; Liang Chen; Robin Patel; Bettina C Fries; Lilian Abbo; Eric Cober; Sara Revolinski; Courtney L Luterbach; Henry Chambers; Vance G Fowler; Robert A Bonomo; Samuel A Shelburne; Barry N Kreiswirth; David van Duin; Blake M Hanson; Cesar A Arias Journal: mBio Date: 2022-03-31 Impact factor: 7.786
Authors: Kira Schmitt; Stefan P Kuster; Katrin Zurfluh; Rahel S Jud; Jane E Sykes; Roger Stephan; Barbara Willi Journal: Antibiotics (Basel) Date: 2021-02-09
Authors: Peijun Ma; Lorrie L He; Alejandro Pironti; Hannah H Laibinis; Christoph M Ernst; Abigail L Manson; Roby P Bhattacharyya; Ashlee M Earl; Jonathan Livny; Deborah T Hung Journal: Elife Date: 2021-04-19 Impact factor: 8.140
Authors: Themoula Charalampous; Adela Alcolea-Medina; Luke B Snell; Tom G S Williams; Rahul Batra; Christopher Alder; Andrea Telatin; Luigi Camporota; Christopher I S Meadows; Duncan Wyncoll; Nicholas A Barrett; Carolyn J Hemsley; Lisa Bryan; William Newsholme; Sara E Boyd; Anna Green; Ula Mahadeva; Amita Patel; Penelope R Cliff; Andrew J Page; Justin O'Grady; Jonathan D Edgeworth Journal: Genome Med Date: 2021-11-17 Impact factor: 11.117
Authors: Gisele Peirano; Liang Chen; Diego Nobrega; Thomas J Finn; Barry N Kreiswirth; Rebekah DeVinney; Johann D D Pitout Journal: Emerg Infect Dis Date: 2022-05 Impact factor: 16.126
Authors: Mathieu Monnheimer; Paul Cooper; Harold K Amegbletor; Theresia Pellio; Uwe Groß; Yvonne Pfeifer; Marco H Schulze Journal: Microorganisms Date: 2021-03-05